About Store

NASS’ Health Policy & Advocacy and Research Councils regularly comment on a variety of policy and scientific topics on behalf of members and patients. Comments are frequently submitted to Congress and regulatory agencies, including CMS and the FDA, as well as quality improvement entities. Recent comment letters are included below VSports. .

Sep 12, 2025
Multisociety letter to CMS on CY2026 Hospital Outpatient Prospective Payment and Abulatory Surgical Central Proposed Rule

View

Sep 12, 2025
Multisociety letter to CMS on CY2026 Medicare Physician Fee Schedule

View

Sep 05, 2025
Alliance of Specialty Medicine Comments on CY2026 Medicare Physician Fee Schedule Proposed Rule

View

Aug 06, 2025
NASS Shows Support of the Resident Physician Shortage Reduction Act (S.2439/H.R.4731)

View

Jun 06, 2025
NASS Signs On to Letter from AAOS to HHS Regarding FY 2026 Hospital Inpatient Prospective Payment System Proposed Rule

View

May 12, 2025
NASS Signs On to Letter Through the MPW from NANS to Humana Regarding Coverage of Peripheral Nerve Stimulation (PNS) Therapy

View

May 09, 2025
NASS Signs On to Letters Through MPW to Multiple Commercial Payor Letters (Aetna, BCBS, etc.) Regarding Vertebral Compression Fracture Time to Treatment

View

Apr 03, 2025
Multisociety Letter to Congress Regarding DoD PRORP Program

View

Apr 03, 2025
Multisociety Letter to Congress to Prioritize Medicare Physician Payment Reform

View

Apr 03, 2025
Multisociety Letter to NIH Urging the Agency to Develop a Transparent, Efficient and Sustainable Indirect Cost Rate Policy

View

Mar 18, 2025
NASS Along with 33 Medical Societies Respond to BMJ Articles Regarding Interventional Spine Procedures

View

Mar 05, 2025
NASS Signs On to Letter to NIH Urging the Agency to Work Collaboratively With Stakeholders and OMB to Develop a Transparent, Efficient, and Sustainable Indirect Cost Rate Policy

View

Feb 10, 2025
Alliance of Specialty Medicine Comment Letter in Support of H.R. 879 the Medicare Patient Access and Practice Stabilization Act

View

Feb 05, 2025
NASS Signs On to Congressional Letter to E&C Health Committee Through MPW Regarding Fentanyl Crisis

View

Feb 03, 2025
NASS Signs On to Congressional Letter to Senate Judiciary Committee Through MPW Regarding Fentanyl Crisis

View

Jan 31, 2025
Alliance's Comments on Draft Legislation to Improve the Medicare GME Program

View

Jan 27, 2025
NASS Signs on to Alliance letter on CY 2026 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule (CMS-4192-P)

View

Oct 09, 2024
NASS Signs On to Letter Through the MPW from NANS to Humana Regarding Closed-Loop SCS

View

Oct 09, 2024
NASS Signs On to Letters Through the MPW from IPSIS to Various MACs (CGS, NGS, Noridian, Palmetto, WPS) Regarding Trigger Point Injection LCD

View

Oct 04, 2024
Alliance’s Comments to ASTP/ONC on the HTI-2 Proposed Rule

View